Arturo Alvarez-Buylla and Erica L. Jackson, of the University of California, San Francisco, and colleagues reported their findings in a paper in the July 20, 2006, Neuron, published by Cell Press. In their studies, they sought to discover whether neural stem cells in the brain called B cells carry a receptor--known as platelet-derived growth factor receptor á (PDGFRá)--for the signaling molecule PDGF.
Neural stem cells are immature cells that serve as the continual source of new brain cells in adults, and PDGF is known as an important regulator of such cells. Also, PDGF has been implicated as a key signaling molecule underlying the formation of brain tumors. PDGF triggers such cell response by plugging into the target receptor on the stem cell, like a key inserting into a lock.
There had been indirect evidence that neural stem cells give rise to brain tumors. "However, it has not been shown in vivo that tumor stem cells are derived from normal stem cells or that a specific population of cells with demonstrated stem cell properties is capable of initiating tumor formation," wrote the researchers.
Using tracers, the researchers discovered that PDGFRá is, indeed, found on the stem cells in both mouse and human brain tissue. They also found that the receptor is triggered by PDGF in the stem cells to regulate their production of mature brain cells. The researchers located the PDGFRá-containing cells in the subventricular zone (SVZ) of the brain, which is the center for production of new brain cells in adults.
The researchers also found that infusing PDGF into mouse brain caused abnormal growth--called hyperplasia--of tumor-like nodules that invaded surrounding brain tissue. Their analysis indicated that the PDGF infusion caused the stem cells to halt their normal production of mature brain cells and launch into the abnormal proliferation pathway. Importantly, the researchers found that stopping the PDGF infusion caused a complete regression of the nodules.
The researchers wrote that "these findings are significant due to our limited knowledge of surface markers for neural stem cells. Our data also provide evidence of a link between these PDGFRá B cells and the early changes associated with tumor initiation, suggesting they may be targets of neoplastic transformation. The regression of atypical hyperplasia after PDGF removal described here suggests that inhibition of PDGF signaling could provide a useful therapy for those gliomas in which the pathway is upregulated, especially given the recovery of the normal architecture after regression of the hyperplasia."
In a preview of the paper in the same issue of Neuron, Santosh Kesari and Charles D. Stiles wrote that the new findings "lend weight" to the argument that the stem cells identified by Alvarez-Buylla and his colleagues are the cells or origin for malignant gliomas. They wrote that such work offers "therapeutic opportunities," emphasizing that "the people that matter the most do not have the luxury of time to watch this work unfold. The median interval from diagnosis to death for patients with malignant glioma is currently only 14 months."
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences